Loading…

miR‐145 regulates myofibroblast differentiation and lung fibrosis

The expression of smooth muscle actin‐α (SMA‐α) by fibroblasts defines phenotypic transition to myofibroblasts and is a primary contributor to contractile force generation by these differentiated cells. Although the regulation of SMA‐α expression has been the focus of many studies, there is presentl...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2013-06, Vol.27 (6), p.2382-2391
Main Authors: Yang, Shanzhong, Cui, Huachun, Xie, Na, Icyuz, Mert, Banerjee, Sami, Antony, Veena B., Abraham, Edward, Thannickal, Victor J., Liu, Gang
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 2391
container_issue 6
container_start_page 2382
container_title The FASEB journal
container_volume 27
creator Yang, Shanzhong
Cui, Huachun
Xie, Na
Icyuz, Mert
Banerjee, Sami
Antony, Veena B.
Abraham, Edward
Thannickal, Victor J.
Liu, Gang
description The expression of smooth muscle actin‐α (SMA‐α) by fibroblasts defines phenotypic transition to myofibroblasts and is a primary contributor to contractile force generation by these differentiated cells. Although the regulation of SMA‐α expression has been the focus of many studies, there is presently only limited information concerning miRNA regulation of lung myofibroblast differentiation and the involvement of these miRNAs in pulmonary fibrosis. To determine the role of miR‐145 in regulating lung myofibroblast differentiation and pulmonary fibrosis. Wild‐type and miR‐145–/– mice were studied. Lung fibrosis models and cell culture systems were employed. miR‐145 mimics or inhibitors were transfected into pulmonary fibroblasts. Fibrogenic and contractile activities of lung fibroblasts were determined. We found that miR‐145 expression is upregulated in TGF‐β1‐reated lung fibroblasts. miR‐145 expression is also increased in the lungs of patients with idiopathic pulmonary fibrosis as compared to in normal human lungs. Overexpression of miR‐145 in lung fibroblasts increased SMA‐α expression, enhanced contractility, and promoted formation of focal and fibrillar adhesions. In contrast, miR‐145 deficiency diminished TGF‐β1 induced SMA‐α expression. miR‐145 did not affect the activity of TGF‐β1, but promoted the activation of latent TGF‐β1. miR‐145 targets KLF4, a known negative regulator of SMA‐α expression. Finally, we found that miR‐145–/– mice are protected from bleomycin‐induced pulmonary fibrosis. miR‐145 plays an important role in the differentiation of lung myofibroblasts. miR‐145 deficiency is protective against bleomycin‐induced lung fibrosis, suggesting that miR‐145 may be a potential target in the development of novel therapies to treat pathological fibrotic disorders.—Yang, S., Cui, H., Xie, N., Icyuz, M., Banerjee, S., Antony, V. B., Abraham, E., Thannickal, V. J., Liu, G. miR‐145 regulates myofibroblast differentiation and lung fibrosis. FASEB J. 27, 2382–2391 (2013). www.fasebj.org
doi_str_mv 10.1096/fj.12-219493
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3659354</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1357497597</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3147-2abbd01f71f31e77c869353d21828e039a7b4348061f74cb8bb2240f92d326bc3</originalsourceid><addsrcrecordid>eNpVkbtO9DAQhS0EguXSUaOUNIEZ27HjBglW3CQkJC61ZSf24lUuS5z8v7bjEXhGnoTAAoJmpjifzhnNIWQf4QhBiWM_P0KaUlRcsTUywYxBKnIB62QCuaKpECzfItsxzgEAAcUm2aKMZ5KinJBpHe7eXl6RZ0nnZkNleheTetn6YLvWVib2SRm8d51r-mD60DaJacqkGppZ8snEEHfJhjdVdHtfe4c8Xpw_TK_Sm9vL6-npTbpgyGVKjbUloJfoGTopi1wolrGSYk5zB0wZaTnjOYiR4YXNraWUg1e0ZFTYgu2Qk5XvYrC1K4vxpM5UetGF2nRL3Zqg_ypNeNKz9p9mIhuT-Ghw-GXQtc-Di72uQyxcVZnGtUPUyDLJlcyUHNGD31k_Id-fGwG5Av6Hyi1_dAT90Yr2c41Ur1rRF_dnFKgEEONk75Z5gTQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1357497597</pqid></control><display><type>article</type><title>miR‐145 regulates myofibroblast differentiation and lung fibrosis</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Yang, Shanzhong ; Cui, Huachun ; Xie, Na ; Icyuz, Mert ; Banerjee, Sami ; Antony, Veena B. ; Abraham, Edward ; Thannickal, Victor J. ; Liu, Gang</creator><creatorcontrib>Yang, Shanzhong ; Cui, Huachun ; Xie, Na ; Icyuz, Mert ; Banerjee, Sami ; Antony, Veena B. ; Abraham, Edward ; Thannickal, Victor J. ; Liu, Gang</creatorcontrib><description>The expression of smooth muscle actin‐α (SMA‐α) by fibroblasts defines phenotypic transition to myofibroblasts and is a primary contributor to contractile force generation by these differentiated cells. Although the regulation of SMA‐α expression has been the focus of many studies, there is presently only limited information concerning miRNA regulation of lung myofibroblast differentiation and the involvement of these miRNAs in pulmonary fibrosis. To determine the role of miR‐145 in regulating lung myofibroblast differentiation and pulmonary fibrosis. Wild‐type and miR‐145–/– mice were studied. Lung fibrosis models and cell culture systems were employed. miR‐145 mimics or inhibitors were transfected into pulmonary fibroblasts. Fibrogenic and contractile activities of lung fibroblasts were determined. We found that miR‐145 expression is upregulated in TGF‐β1‐reated lung fibroblasts. miR‐145 expression is also increased in the lungs of patients with idiopathic pulmonary fibrosis as compared to in normal human lungs. Overexpression of miR‐145 in lung fibroblasts increased SMA‐α expression, enhanced contractility, and promoted formation of focal and fibrillar adhesions. In contrast, miR‐145 deficiency diminished TGF‐β1 induced SMA‐α expression. miR‐145 did not affect the activity of TGF‐β1, but promoted the activation of latent TGF‐β1. miR‐145 targets KLF4, a known negative regulator of SMA‐α expression. Finally, we found that miR‐145–/– mice are protected from bleomycin‐induced pulmonary fibrosis. miR‐145 plays an important role in the differentiation of lung myofibroblasts. miR‐145 deficiency is protective against bleomycin‐induced lung fibrosis, suggesting that miR‐145 may be a potential target in the development of novel therapies to treat pathological fibrotic disorders.—Yang, S., Cui, H., Xie, N., Icyuz, M., Banerjee, S., Antony, V. B., Abraham, E., Thannickal, V. J., Liu, G. miR‐145 regulates myofibroblast differentiation and lung fibrosis. FASEB J. 27, 2382–2391 (2013). www.fasebj.org</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.12-219493</identifier><identifier>PMID: 23457217</identifier><language>eng</language><publisher>Bethesda, MD, USA: Federation of American Societies for Experimental Biology</publisher><subject>Animals ; Cell Differentiation - genetics ; Cell Differentiation - physiology ; Cell Line ; Cells, Cultured ; contraction ; Disease Models, Animal ; Humans ; Idiopathic Pulmonary Fibrosis - genetics ; Idiopathic Pulmonary Fibrosis - metabolism ; Idiopathic Pulmonary Fibrosis - pathology ; KLF4 ; Kruppel-Like Factor 4 ; Lung - cytology ; Lung - metabolism ; Lung - pathology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; MicroRNAs - genetics ; MicroRNAs - physiology ; Myofibroblasts - cytology ; Myofibroblasts - metabolism ; Research Communications ; smooth muscle actin α</subject><ispartof>The FASEB journal, 2013-06, Vol.27 (6), p.2382-2391</ispartof><rights>FASEB</rights><rights>FASEB 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23457217$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Shanzhong</creatorcontrib><creatorcontrib>Cui, Huachun</creatorcontrib><creatorcontrib>Xie, Na</creatorcontrib><creatorcontrib>Icyuz, Mert</creatorcontrib><creatorcontrib>Banerjee, Sami</creatorcontrib><creatorcontrib>Antony, Veena B.</creatorcontrib><creatorcontrib>Abraham, Edward</creatorcontrib><creatorcontrib>Thannickal, Victor J.</creatorcontrib><creatorcontrib>Liu, Gang</creatorcontrib><title>miR‐145 regulates myofibroblast differentiation and lung fibrosis</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>The expression of smooth muscle actin‐α (SMA‐α) by fibroblasts defines phenotypic transition to myofibroblasts and is a primary contributor to contractile force generation by these differentiated cells. Although the regulation of SMA‐α expression has been the focus of many studies, there is presently only limited information concerning miRNA regulation of lung myofibroblast differentiation and the involvement of these miRNAs in pulmonary fibrosis. To determine the role of miR‐145 in regulating lung myofibroblast differentiation and pulmonary fibrosis. Wild‐type and miR‐145–/– mice were studied. Lung fibrosis models and cell culture systems were employed. miR‐145 mimics or inhibitors were transfected into pulmonary fibroblasts. Fibrogenic and contractile activities of lung fibroblasts were determined. We found that miR‐145 expression is upregulated in TGF‐β1‐reated lung fibroblasts. miR‐145 expression is also increased in the lungs of patients with idiopathic pulmonary fibrosis as compared to in normal human lungs. Overexpression of miR‐145 in lung fibroblasts increased SMA‐α expression, enhanced contractility, and promoted formation of focal and fibrillar adhesions. In contrast, miR‐145 deficiency diminished TGF‐β1 induced SMA‐α expression. miR‐145 did not affect the activity of TGF‐β1, but promoted the activation of latent TGF‐β1. miR‐145 targets KLF4, a known negative regulator of SMA‐α expression. Finally, we found that miR‐145–/– mice are protected from bleomycin‐induced pulmonary fibrosis. miR‐145 plays an important role in the differentiation of lung myofibroblasts. miR‐145 deficiency is protective against bleomycin‐induced lung fibrosis, suggesting that miR‐145 may be a potential target in the development of novel therapies to treat pathological fibrotic disorders.—Yang, S., Cui, H., Xie, N., Icyuz, M., Banerjee, S., Antony, V. B., Abraham, E., Thannickal, V. J., Liu, G. miR‐145 regulates myofibroblast differentiation and lung fibrosis. FASEB J. 27, 2382–2391 (2013). www.fasebj.org</description><subject>Animals</subject><subject>Cell Differentiation - genetics</subject><subject>Cell Differentiation - physiology</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>contraction</subject><subject>Disease Models, Animal</subject><subject>Humans</subject><subject>Idiopathic Pulmonary Fibrosis - genetics</subject><subject>Idiopathic Pulmonary Fibrosis - metabolism</subject><subject>Idiopathic Pulmonary Fibrosis - pathology</subject><subject>KLF4</subject><subject>Kruppel-Like Factor 4</subject><subject>Lung - cytology</subject><subject>Lung - metabolism</subject><subject>Lung - pathology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - physiology</subject><subject>Myofibroblasts - cytology</subject><subject>Myofibroblasts - metabolism</subject><subject>Research Communications</subject><subject>smooth muscle actin α</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpVkbtO9DAQhS0EguXSUaOUNIEZ27HjBglW3CQkJC61ZSf24lUuS5z8v7bjEXhGnoTAAoJmpjifzhnNIWQf4QhBiWM_P0KaUlRcsTUywYxBKnIB62QCuaKpECzfItsxzgEAAcUm2aKMZ5KinJBpHe7eXl6RZ0nnZkNleheTetn6YLvWVib2SRm8d51r-mD60DaJacqkGppZ8snEEHfJhjdVdHtfe4c8Xpw_TK_Sm9vL6-npTbpgyGVKjbUloJfoGTopi1wolrGSYk5zB0wZaTnjOYiR4YXNraWUg1e0ZFTYgu2Qk5XvYrC1K4vxpM5UetGF2nRL3Zqg_ypNeNKz9p9mIhuT-Ghw-GXQtc-Di72uQyxcVZnGtUPUyDLJlcyUHNGD31k_Id-fGwG5Av6Hyi1_dAT90Yr2c41Ur1rRF_dnFKgEEONk75Z5gTQ</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Yang, Shanzhong</creator><creator>Cui, Huachun</creator><creator>Xie, Na</creator><creator>Icyuz, Mert</creator><creator>Banerjee, Sami</creator><creator>Antony, Veena B.</creator><creator>Abraham, Edward</creator><creator>Thannickal, Victor J.</creator><creator>Liu, Gang</creator><general>Federation of American Societies for Experimental Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201306</creationdate><title>miR‐145 regulates myofibroblast differentiation and lung fibrosis</title><author>Yang, Shanzhong ; Cui, Huachun ; Xie, Na ; Icyuz, Mert ; Banerjee, Sami ; Antony, Veena B. ; Abraham, Edward ; Thannickal, Victor J. ; Liu, Gang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3147-2abbd01f71f31e77c869353d21828e039a7b4348061f74cb8bb2240f92d326bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Cell Differentiation - genetics</topic><topic>Cell Differentiation - physiology</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>contraction</topic><topic>Disease Models, Animal</topic><topic>Humans</topic><topic>Idiopathic Pulmonary Fibrosis - genetics</topic><topic>Idiopathic Pulmonary Fibrosis - metabolism</topic><topic>Idiopathic Pulmonary Fibrosis - pathology</topic><topic>KLF4</topic><topic>Kruppel-Like Factor 4</topic><topic>Lung - cytology</topic><topic>Lung - metabolism</topic><topic>Lung - pathology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - physiology</topic><topic>Myofibroblasts - cytology</topic><topic>Myofibroblasts - metabolism</topic><topic>Research Communications</topic><topic>smooth muscle actin α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Shanzhong</creatorcontrib><creatorcontrib>Cui, Huachun</creatorcontrib><creatorcontrib>Xie, Na</creatorcontrib><creatorcontrib>Icyuz, Mert</creatorcontrib><creatorcontrib>Banerjee, Sami</creatorcontrib><creatorcontrib>Antony, Veena B.</creatorcontrib><creatorcontrib>Abraham, Edward</creatorcontrib><creatorcontrib>Thannickal, Victor J.</creatorcontrib><creatorcontrib>Liu, Gang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Shanzhong</au><au>Cui, Huachun</au><au>Xie, Na</au><au>Icyuz, Mert</au><au>Banerjee, Sami</au><au>Antony, Veena B.</au><au>Abraham, Edward</au><au>Thannickal, Victor J.</au><au>Liu, Gang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miR‐145 regulates myofibroblast differentiation and lung fibrosis</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2013-06</date><risdate>2013</risdate><volume>27</volume><issue>6</issue><spage>2382</spage><epage>2391</epage><pages>2382-2391</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>The expression of smooth muscle actin‐α (SMA‐α) by fibroblasts defines phenotypic transition to myofibroblasts and is a primary contributor to contractile force generation by these differentiated cells. Although the regulation of SMA‐α expression has been the focus of many studies, there is presently only limited information concerning miRNA regulation of lung myofibroblast differentiation and the involvement of these miRNAs in pulmonary fibrosis. To determine the role of miR‐145 in regulating lung myofibroblast differentiation and pulmonary fibrosis. Wild‐type and miR‐145–/– mice were studied. Lung fibrosis models and cell culture systems were employed. miR‐145 mimics or inhibitors were transfected into pulmonary fibroblasts. Fibrogenic and contractile activities of lung fibroblasts were determined. We found that miR‐145 expression is upregulated in TGF‐β1‐reated lung fibroblasts. miR‐145 expression is also increased in the lungs of patients with idiopathic pulmonary fibrosis as compared to in normal human lungs. Overexpression of miR‐145 in lung fibroblasts increased SMA‐α expression, enhanced contractility, and promoted formation of focal and fibrillar adhesions. In contrast, miR‐145 deficiency diminished TGF‐β1 induced SMA‐α expression. miR‐145 did not affect the activity of TGF‐β1, but promoted the activation of latent TGF‐β1. miR‐145 targets KLF4, a known negative regulator of SMA‐α expression. Finally, we found that miR‐145–/– mice are protected from bleomycin‐induced pulmonary fibrosis. miR‐145 plays an important role in the differentiation of lung myofibroblasts. miR‐145 deficiency is protective against bleomycin‐induced lung fibrosis, suggesting that miR‐145 may be a potential target in the development of novel therapies to treat pathological fibrotic disorders.—Yang, S., Cui, H., Xie, N., Icyuz, M., Banerjee, S., Antony, V. B., Abraham, E., Thannickal, V. J., Liu, G. miR‐145 regulates myofibroblast differentiation and lung fibrosis. FASEB J. 27, 2382–2391 (2013). www.fasebj.org</abstract><cop>Bethesda, MD, USA</cop><pub>Federation of American Societies for Experimental Biology</pub><pmid>23457217</pmid><doi>10.1096/fj.12-219493</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0892-6638
ispartof The FASEB journal, 2013-06, Vol.27 (6), p.2382-2391
issn 0892-6638
1530-6860
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3659354
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Cell Differentiation - genetics
Cell Differentiation - physiology
Cell Line
Cells, Cultured
contraction
Disease Models, Animal
Humans
Idiopathic Pulmonary Fibrosis - genetics
Idiopathic Pulmonary Fibrosis - metabolism
Idiopathic Pulmonary Fibrosis - pathology
KLF4
Kruppel-Like Factor 4
Lung - cytology
Lung - metabolism
Lung - pathology
Mice
Mice, Inbred C57BL
Mice, Knockout
MicroRNAs - genetics
MicroRNAs - physiology
Myofibroblasts - cytology
Myofibroblasts - metabolism
Research Communications
smooth muscle actin α
title miR‐145 regulates myofibroblast differentiation and lung fibrosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A48%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miR%E2%80%90145%20regulates%20myofibroblast%20differentiation%20and%20lung%20fibrosis&rft.jtitle=The%20FASEB%20journal&rft.au=Yang,%20Shanzhong&rft.date=2013-06&rft.volume=27&rft.issue=6&rft.spage=2382&rft.epage=2391&rft.pages=2382-2391&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.12-219493&rft_dat=%3Cproquest_pubme%3E1357497597%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3147-2abbd01f71f31e77c869353d21828e039a7b4348061f74cb8bb2240f92d326bc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1357497597&rft_id=info:pmid/23457217&rfr_iscdi=true